Appropriateness of pharmacological treatment in older people with dementia
Dementia is associated with a number of comorbidities often observed in older people, including hypertension, cardiovascular disease, stroke and diabetes. Treating these comorbidities in older adults with dementia results challenging for many reasons. First, older adults with dementia are generally...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2015-09-01
|
Series: | Italian Journal of Medicine |
Subjects: | |
Online Access: | http://www.italjmed.org/index.php/ijm/article/view/539 |
_version_ | 1827613974974169088 |
---|---|
author | Eleonora Meloni Davide Liborio Vetrano Roberto Bernabei Graziano Onder |
author_facet | Eleonora Meloni Davide Liborio Vetrano Roberto Bernabei Graziano Onder |
author_sort | Eleonora Meloni |
collection | DOAJ |
description | Dementia is associated with a number of comorbidities often observed in older people, including hypertension, cardiovascular disease, stroke and diabetes. Treating these comorbidities in older adults with dementia results challenging for many reasons. First, older adults with dementia are generally excluded from clinical trials, so application of clinical guidelines for treatment of chronic diseases in this population might lead to polypharmacy and adverse drugs effects. Second, memory, intellectual function, judgment and language are commonly impaired in patients with cognitive deficits, compromising the compliance to complex pharmacological regimens, increasing the risk of adverse drug reactions. Third, cognitive impairment is associated with limited life expectancy and therefore limits the efficacy of pharmacological treatments and questions the appropriateness of treatment. In the present study we examine most relevant concerns related to the treatment of comorbidities in demented patients, referring also to the existing criteria for inappropriate drugs in the elderly. The application of such instruments, along with the comprehensive geriatric assessment of the older adult with cognitive impairment, could result useful to reduce the burden of polypharmacy and inappropriate drug prescriptions. |
first_indexed | 2024-03-09T08:48:24Z |
format | Article |
id | doaj.art-d837f0ab19a149148b0b20bd1f02e21e |
institution | Directory Open Access Journal |
issn | 1877-9344 1877-9352 |
language | English |
last_indexed | 2024-03-09T08:48:24Z |
publishDate | 2015-09-01 |
publisher | PAGEPress Publications |
record_format | Article |
series | Italian Journal of Medicine |
spelling | doaj.art-d837f0ab19a149148b0b20bd1f02e21e2023-12-02T15:02:13ZengPAGEPress PublicationsItalian Journal of Medicine1877-93441877-93522015-09-019321221610.4081/itjm.2015.539490Appropriateness of pharmacological treatment in older people with dementiaEleonora Meloni0Davide Liborio Vetrano1Roberto Bernabei2Graziano Onder3Department of Geriatrics, Neurosciences and Orthopedics, Catholic University of Sacred Heart, RomeDepartment of Geriatrics, Neurosciences and Orthopedics, Catholic University of Sacred Heart, RomeDepartment of Geriatrics, Neurosciences and Orthopedics, Catholic University of Sacred Heart, RomeDepartment of Geriatrics, Neurosciences and Orthopedics, Catholic University of Sacred Heart, RomeDementia is associated with a number of comorbidities often observed in older people, including hypertension, cardiovascular disease, stroke and diabetes. Treating these comorbidities in older adults with dementia results challenging for many reasons. First, older adults with dementia are generally excluded from clinical trials, so application of clinical guidelines for treatment of chronic diseases in this population might lead to polypharmacy and adverse drugs effects. Second, memory, intellectual function, judgment and language are commonly impaired in patients with cognitive deficits, compromising the compliance to complex pharmacological regimens, increasing the risk of adverse drug reactions. Third, cognitive impairment is associated with limited life expectancy and therefore limits the efficacy of pharmacological treatments and questions the appropriateness of treatment. In the present study we examine most relevant concerns related to the treatment of comorbidities in demented patients, referring also to the existing criteria for inappropriate drugs in the elderly. The application of such instruments, along with the comprehensive geriatric assessment of the older adult with cognitive impairment, could result useful to reduce the burden of polypharmacy and inappropriate drug prescriptions.http://www.italjmed.org/index.php/ijm/article/view/539Dementiaelderlyinappropriate therapymultimorbiditypolypharmacy. |
spellingShingle | Eleonora Meloni Davide Liborio Vetrano Roberto Bernabei Graziano Onder Appropriateness of pharmacological treatment in older people with dementia Italian Journal of Medicine Dementia elderly inappropriate therapy multimorbidity polypharmacy. |
title | Appropriateness of pharmacological treatment in older people with dementia |
title_full | Appropriateness of pharmacological treatment in older people with dementia |
title_fullStr | Appropriateness of pharmacological treatment in older people with dementia |
title_full_unstemmed | Appropriateness of pharmacological treatment in older people with dementia |
title_short | Appropriateness of pharmacological treatment in older people with dementia |
title_sort | appropriateness of pharmacological treatment in older people with dementia |
topic | Dementia elderly inappropriate therapy multimorbidity polypharmacy. |
url | http://www.italjmed.org/index.php/ijm/article/view/539 |
work_keys_str_mv | AT eleonorameloni appropriatenessofpharmacologicaltreatmentinolderpeoplewithdementia AT davideliboriovetrano appropriatenessofpharmacologicaltreatmentinolderpeoplewithdementia AT robertobernabei appropriatenessofpharmacologicaltreatmentinolderpeoplewithdementia AT grazianoonder appropriatenessofpharmacologicaltreatmentinolderpeoplewithdementia |